VAXX Latest Quarter's Earnings
| Announce Date | 05/14/2024 |
| EPS Normalized Actual | $-0.15 (Miss by $-0.05) |
| EPS GAAP Actual | $-0.15 (Miss by $-0.05) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
Upcoming Quarter's Earnings
| Announce Date | 03/31/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.36 |
| EPS GAAP Estimate | $-0.36 |
| Revenue Estimate | $0B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | -0.41 | -0.04 | -0.41 | -0.41 | 0 |
| Dec 2026 | -0.41 | -0.04 | -0.41 | -0.41 | 1 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2020 (Mar 2020) | -0.11 | -0.11 | 0B | NAN% | 0M |
| FQ4 2023 (Dec 2023) | -0.0899 | -0.0899 | 0B | NAN% | 0M |
| FQ3 2023 (Sep 2023) | -0.1 | -0.1 | 0B | NAN% | 0M |
| FQ3 2020 (Sep 2020) | -0.13 | -0.13 | 0.000117B | 100% | 0.12M |
| FQ4 2020 (Dec 2020) | 0 | 0 | 0B | NAN% | 0M |
| FQ1 2021 (Mar 2021) | -0.26 | -0.26 | 1.7E-5B | 100% | 0.02M |
| FQ3 2021 (Sep 2021) | -0.24 | -0.24 | 5.0E-5B | -134% | 0.05M |
| FQ4 2021 (Dec 2021) | 0 | 0 | -1.0E-6B | 100% | -0M |
Quarterly Estimates Summary
FQ4 Announce Date
03/31/2026 (Pre-Market)
Consensus EPS Estimates
-0.36
Consensus Revenue Estimates
0B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2029 (Jun 2029) | -0.08 | -- | -0.08 | -0.08 | 1 |
| FQ1 2029 (Mar 2029) | -0.08 | -- | -0.08 | -0.08 | 1 |
| FQ4 2028 (Dec 2028) | -0.1 | -- | -0.1 | -0.1 | 1 |
| FQ3 2028 (Sep 2028) | -0.1 | -- | -0.1 | -0.1 | 1 |
| FQ2 2028 (Jun 2028) | -0.1 | -- | -0.1 | -0.1 | 1 |
| FQ1 2028 (Mar 2028) | -0.1 | -- | -0.1 | -0.1 | 1 |
| FQ3 2027 (Sep 2027) | -0.155 | -- | -0.155 | -0.155 | 1 |
| FQ2 2027 (Jun 2027) | -0.15 | -- | -0.15 | -0.15 | 1 |
| FQ1 2027 (Mar 2027) | -0.16 | -- | -0.16 | -0.16 | 1 |
| FQ3 2026 (Sep 2026) | -0.375 | -- | -0.375 | -0.375 | 1 |
| FQ2 2026 (Jun 2026) | -0.34 | -- | -0.34 | -0.34 | 1 |
| FQ1 2026 (Mar 2026) | -0.36 | -- | -0.36 | -0.36 | 1 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2029 (Jun 2029) | 0B | -- | 0B | 0B | 0 |
| FQ1 2029 (Mar 2029) | 0B | -- | 0B | 0B | 0 |
| FQ4 2028 (Dec 2028) | 0B | -- | 0B | 0B | 0 |
| FQ3 2028 (Sep 2028) | 0B | -- | 0B | 0B | 0 |
| FQ2 2028 (Jun 2028) | 0B | -- | 0B | 0B | 0 |
| FQ1 2028 (Mar 2028) | 0B | -- | 0B | 0B | 0 |
| FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 0 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 0 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 0 |
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 0 |
| FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 0 |
| FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 0 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
0
EPS # of Misses
6
EPS # of in-lines
2
Revenue # of Beats
3
Revenue # of Misses
1
Revenue # of in-lines
4
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2020 (Mar 2020) | -0.11 | -0.11 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0899 | -0.0899 | 100% | |
| FQ3 2023 (Sep 2023) | -0.1 | -0.1 | 100% | |
| FQ3 2020 (Sep 2020) | -0.13 | -0.13 | 100% | |
| FQ4 2020 (Dec 2020) | 0 | 0 | NAN% | |
| FQ1 2021 (Mar 2021) | -0.26 | -0.26 | 100% | |
| FQ3 2021 (Sep 2021) | -0.24 | -0.24 | 100% | |
| FQ4 2021 (Dec 2021) | 0 | 0 | NAN% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2020 (Mar 2020) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
| FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |
| FQ3 2020 (Sep 2020) | $0B | $0B | $0.12M | 100% |
| FQ4 2020 (Dec 2020) | $0B | $0B | $0M | NAN% |
| FQ1 2021 (Mar 2021) | $0B | $0B | $0.02M | 100% |
| FQ3 2021 (Sep 2021) | $0B | $0B | $0.05M | 100% |
| FQ4 2021 (Dec 2021) | $0B | $-0B | $-0M | 100% |
VAXX Ratings Summary
VAXX Quant Ranking
